TWINSTRAND BIOSCIENCES INC.

In News

Del. Judge Won't Touch Jury's $83M Diagnostics IP Verdict - Law360

Law360 - Jun 16, 2026

Guardant Fails to Undo $83 Million DNA-Tech Patent Verdict (1) - Bloomberg Law News

Bloomberg Law News - Jun 17, 2026

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology - PR Newswire

PR Newswire - Jul 31, 2024

Guardant Can Try Again To Nix Patent Tied To $83M Verdict - Law360

Law360 - Jan 23, 2026

Guardant Health hit with $83M verdict in TwinStrand DNA sequencing patent lawsuit - fiercebiotech.com

fiercebiotech.com - Nov 15, 2023

Duplex Sequencing Technology Detects Early Carcinogen-Caused Mutagenesis - The American Journal of Managed Care

The American Journal of Managed Care - Dec 18, 2020

Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says - Reuters

Reuters - Nov 15, 2023

Frequency and spectrum of mutations in human sperm measured using duplex sequencing correlate with trio-based de novo mutation analyses - Nature

Nature - Oct 08, 2024

Novo Nordisk laying off 86 workers as part of lab shutdown in Seattle - GeekWire

GeekWire - Mar 01, 2023

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 06, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment